By: IPP Bureau
Last updated : January 14, 2023 11:33 am
This will give either party customers access enzyme expertise and assets, resulting in cost-effective, green processing for API manufacturing.
Quantumzyme LLP (Quantumzyme), a Bangalore-based biotransformation company, focused on clean and green chemistry announced today that they have collaborated with BEC Chemicals Private Limited in biocatalysis to develop sustainable biotransformation and biocatalysis solution for the pharmaceutical industry.
The agreement grants both parties access to each other’s knowledge and expertise to develop novel solutions for Active Pharmaceutical Ingredient (API) development. Quantumzyme’s expertise in rapid enzyme discovery, enzyme engineering, and pilot validation into early-phase projects complements BEC Chemicals' experience and track record of over 30 commercial manufacturing chemical reactions run on a multi-ton scale. This will give either party customers access enzyme expertise and assets, resulting in cost-effective, green processing for API manufacturing.
Megha Shah, Managing Director of BEC Chemicals, stated, "Working with Quantumzyme, marks further advancement of BEC Chemicals' strategy towards technology partnerships to provide additional value to our customers while developing sustainable solutions to the industry. We are proud to be a leader in intermediate and API production for domestic and regulated markets as well as providing high-quality custom manufacturing and development services to the pharmaceutical industries. Via this agreement, we maintain our commitment to craft the future of pharma manufacturing, adding to our green chemistry toolbox and more efficient manufacturing.”
Naveen Kulkarni, the CEO of Quantumzyme, stated, "While India is the global leader in API export, there is a need for early adopters to set examples for the industry to follow when it comes to new technologies. Traditionally India has always been home to complex chemistry and now the time has come to switch gears and leverage the advances and development in biotechnology for sustainable chemistry. We are glad to announce our partnership with BEC Chemicals which is leading this from the forefront. This collaboration has come at the right time as more and more customers need scalable green technologies to access difficult-to-make chiral chemicals.
Our customers will see real rewards from the fact that any process developed can go from conception to manufacturing quickly with our technology. One important success factor for implementing enzymatic routes is access to a diverse range of biocatalysts. Quantumzyme is continuously expanding its unique enzyme collection through in-house development as well as innovative partnering models. The collaboration with BEC Chemicals completes the latest phase in this process -- bringing biocatalysis to the next level."